heart disease
The CardioGenomic Testing Alliance aims to increase the utilization of NGS panels for numerous cardiac conditions including arrhythmias and cardiomyopathies.
International Heart Rhythm Societies Set Out Recommendations on Genetic Testing for Cardiac Diseases
The consensus statement, published this week, should help to guide decision-making around genetic testing for a variety of cardiac conditions.
Prolight Diagnostics to Acquire UK Point-of-Care Firm Psyros Diagnostics for $7.1M
Psyros said its single-molecule counting technology would enable multiplexing and the measurement of biomarkers at femtomolar concentrations in 10 minutes or less.
NHS, Genomics PLC to Integrate Polygenic Risk Scores With Traditional Cardiovascular Risk Factors
A newly launched pilot study aims to demonstrate the effectiveness of genetic risk assessment in preventing cardiovascular disease in England.
The company, which received CE marking for its high sensitivity troponin I assay and Atellica VTLi Patient-side Immunoassay Analyzer, plans to enter the US market.